Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma med. app.

By: Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL
Published in: Cancer Med 2014; 3 (3): 592-602
Download citation in RIS format

Exposure